PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
18418668-9	2008	Further analysis of TRH-deficient mice revealed that the expression of PFTAIRE protein kinase1 (PFTK1), a cdc2-related kinase, in the cerebellum was induced by TRH through the NO-cGMP pathway.	Cyclic GMP	179-183	cyclin-dependent kinase 14	Mus musculus	71-94
18418668-9	2008	Further analysis of TRH-deficient mice revealed that the expression of PFTAIRE protein kinase1 (PFTK1), a cdc2-related kinase, in the cerebellum was induced by TRH through the NO-cGMP pathway.	Cyclic GMP	179-183	cyclin-dependent kinase 14	Mus musculus	96-101
33209486-0	2020	The anti-tumor effect of miR-539-3p on colon cancer via regulating cell viability, motility, and nude mouse tumorigenicity with CDK14 inhibition.	mir-539-3p	25-35	cyclin-dependent kinase 14	Mus musculus	128-133
12072416-7	2002	In addition, treatment of 8-Br-cGMP significantly increased PFTK1 mRNA levels, and a specific inhibitor of cGMP production, ODQ, completely blocked TRH-induced expression of PFTK1 mRNA.	8-bromoguanosino-3',5'-cyclic monophosphorothioate	26-35	cyclin-dependent kinase 14	Mus musculus	60-65
12072416-7	2002	In addition, treatment of 8-Br-cGMP significantly increased PFTK1 mRNA levels, and a specific inhibitor of cGMP production, ODQ, completely blocked TRH-induced expression of PFTK1 mRNA.	8-bromoguanosino-3',5'-cyclic monophosphorothioate	26-35	cyclin-dependent kinase 14	Mus musculus	174-179
12072416-7	2002	In addition, treatment of 8-Br-cGMP significantly increased PFTK1 mRNA levels, and a specific inhibitor of cGMP production, ODQ, completely blocked TRH-induced expression of PFTK1 mRNA.	Cyclic GMP	31-35	cyclin-dependent kinase 14	Mus musculus	60-65
12072416-7	2002	In addition, treatment of 8-Br-cGMP significantly increased PFTK1 mRNA levels, and a specific inhibitor of cGMP production, ODQ, completely blocked TRH-induced expression of PFTK1 mRNA.	Cyclic GMP	31-35	cyclin-dependent kinase 14	Mus musculus	174-179
12072416-7	2002	In addition, treatment of 8-Br-cGMP significantly increased PFTK1 mRNA levels, and a specific inhibitor of cGMP production, ODQ, completely blocked TRH-induced expression of PFTK1 mRNA.	1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one	124-127	cyclin-dependent kinase 14	Mus musculus	174-179
12072416-9	2002	These findings demonstrated, for the first time, a novel pathway between a neuropeptide and a cell cycle related peptide in the brain, and PFTK1 may be a key regulator for TRH action in t he cerebellum through t he NO-cGMP pathway.	Cyclic GMP	218-222	cyclin-dependent kinase 14	Mus musculus	139-144
35456420-11	2022	Cdk14, one of only three genes in a Chromosome5 QTL, is associated with handling induced convulsions after ethanol treatment, that is regulated by the anticonvulsant drug valproic acid.	Ethanol	107-114	cyclin-dependent kinase 14	Mus musculus	0-5
35456420-11	2022	Cdk14, one of only three genes in a Chromosome5 QTL, is associated with handling induced convulsions after ethanol treatment, that is regulated by the anticonvulsant drug valproic acid.	Valproic Acid	171-184	cyclin-dependent kinase 14	Mus musculus	0-5
33871149-2	2022	CDK14, a new oncogenic member of CDK family involving in pancreatic cancer cell response to Gemcitabine (GEM) treatment, has been reported to be regulated by miRNAs.	gemcitabine	92-103	cyclin-dependent kinase 14	Mus musculus	0-5
33871149-2	2022	CDK14, a new oncogenic member of CDK family involving in pancreatic cancer cell response to Gemcitabine (GEM) treatment, has been reported to be regulated by miRNAs.	gemcitabine	92-103	cyclin-dependent kinase 14	Mus musculus	0-3
33871149-2	2022	CDK14, a new oncogenic member of CDK family involving in pancreatic cancer cell response to Gemcitabine (GEM) treatment, has been reported to be regulated by miRNAs.	gemcitabine	105-108	cyclin-dependent kinase 14	Mus musculus	0-5
33871149-2	2022	CDK14, a new oncogenic member of CDK family involving in pancreatic cancer cell response to Gemcitabine (GEM) treatment, has been reported to be regulated by miRNAs.	gemcitabine	105-108	cyclin-dependent kinase 14	Mus musculus	0-3
33209486-3	2020	This study aimed to investigate the anti-tumor effect of micro ribonucleic acid 539-3p (miR-539-3p) on colon cancer via regulation of cell viability, motility, and nude mouse tumorigenicity with cyclin-dependent kinase 14 (CDK14) inhibition.	micro ribonucleic acid	57-79	cyclin-dependent kinase 14	Mus musculus	195-221
33209486-3	2020	This study aimed to investigate the anti-tumor effect of micro ribonucleic acid 539-3p (miR-539-3p) on colon cancer via regulation of cell viability, motility, and nude mouse tumorigenicity with cyclin-dependent kinase 14 (CDK14) inhibition.	micro ribonucleic acid	57-79	cyclin-dependent kinase 14	Mus musculus	223-228
25680692-5	2015	Cdk14 is expressed in all testicular cells; spermatogonia- and Sertoli-derived cell lines treated with cigarette smoke extract (CSE) in vitro showed down-regulation of CDK14 mRNA and protein levels as well as down-regulation of beta-catenin levels.	cigarette smoke	103-118	cyclin-dependent kinase 14	Mus musculus	0-5
25680692-5	2015	Cdk14 is expressed in all testicular cells; spermatogonia- and Sertoli-derived cell lines treated with cigarette smoke extract (CSE) in vitro showed down-regulation of CDK14 mRNA and protein levels as well as down-regulation of beta-catenin levels.	cigarette smoke	103-118	cyclin-dependent kinase 14	Mus musculus	168-173
25680692-7	2015	Similar to testicular cells, CS-induced down-regulation of CDK14 in lung cells correlated with decreased levels of beta-catenin, a finding suggesting impaired Wnt signaling.	Cesium	29-31	cyclin-dependent kinase 14	Mus musculus	59-64